-
JAMA Cardiology
Original Investigation
February 21, 2024
Michael T.ÌýLu,ÌýMD, MPH; HeatherÌýRibaudo,ÌýPhD; BorekÌýFoldyna,ÌýMD; Markella V.ÌýZanni,ÌýMD; ThomasÌýMayrhofer,ÌýPhD; JuliaÌýKarady,ÌýMD, PhD; JanaÌýTaron,ÌýMD; Kathleen V.ÌýFitch,ÌýMSN; SaraÌýMcCallum,ÌýMPH; Tricia H.ÌýBurdo,ÌýPhD; KaylaÌýParadis,ÌýMBA; Sandeep S.ÌýHedgire,ÌýMD; Nandini M.ÌýMeyersohn,ÌýMD; ChristopherÌýDeFilippi,ÌýMD; Carlos D.ÌýMalvestutto,ÌýMD, MPH; AudraÌýSturniolo,ÌýMS; MarissaÌýDiggs,ÌýBA; SueÌýSiminski,ÌýMBA; Gerald S.ÌýBloomfield,ÌýMD; BeverlyÌýAlston-Smith,ÌýMD; PatriceÌýDesvigne-Nickens,ÌýMD; Edgar T.ÌýOverton,ÌýMD; Judith S.ÌýCurrier,ÌýMD; Judith A.ÌýAberg,ÌýMD; Carl J.ÌýFichtenbaum,ÌýMD; UdoÌýHoffmann,ÌýMD, MPH; Pamela S.ÌýDouglas,ÌýMD; Steven K.ÌýGrinspoon,ÌýMD; REPRIEVE Trial Writing Group
open access
has multimedia
JAMA Cardiol. 2024; 9(4):323-334. 10.1001/jamacardio.2023.5661
This substudy of a randomized clinical trial investigates the effects of pitavastatin on noncalcified coronary artery plaque using coronary computed tomography angiography and on inflammatory biomarkers as potential mechanisms for major adverse cardiovascular event prevention.
-
JAMA
Original Investigation
January 17, 2023
Robert J.ÌýMentz,ÌýMD; Kevin J.ÌýAnstrom,ÌýPhD; Eric L.ÌýEisenstein,ÌýDBA; ShellyÌýSapp,ÌýMS; Stephen J.ÌýGreene,ÌýMD; ShelbyÌýMorgan,ÌýBSN; Jeffrey M.ÌýTestani,ÌýMD, MTR; Amanda H.ÌýHarrington,ÌýBSW; VandanaÌýSachdev,ÌýMD; FassilÌýKetema,ÌýMSc; Dong-YunÌýKim,ÌýPhD; PatriceÌýDesvigne-Nickens,ÌýMD; BertramÌýPitt,ÌýMD; Eric J.ÌýVelazquez,ÌýMD; TRANSFORM-HF Investigators
free access
JAMA. 2023; 329(3):214-223. 10.1001/jama.2022.23924
This clinical trial compares the efficacy of torsemide vs furosemide in decreasing the risk of death from any cause among patients hospitalized for heart failure (regardless of ejection fraction).
-
JAMA Cardiology
Special Communication
December 7, 2022
Emelia J.ÌýBenjamin,ÌýMD, ScM; Kevin L.ÌýThomas,ÌýMD; Alan S.ÌýGo,ÌýMD; PatriceÌýDesvigne-Nickens,ÌýMD; Christine M.ÌýAlbert,ÌýMD, MPH; AlvaroÌýAlonso,ÌýMD, PhD; Alanna M.ÌýChamberlain,ÌýPhD; Utibe R.ÌýEssien,ÌýMD, MPH; InmaculadaÌýHernandez,ÌýPharmD, PhD; Mellanie TrueÌýHills,ÌýBS; Kiarri N.ÌýKershaw,ÌýPhD, MPH; Phillip D.ÌýLevy,ÌýMD, MPH; Jared W.ÌýMagnani,ÌýMD, MSc; Daniel D.ÌýMatlock,ÌýMD, MPH; Emily C.ÌýO’Brien,ÌýPhD; Carlos J.ÌýRodriguez,ÌýMD, MPH; Andrea M.ÌýRusso,ÌýMD; Elsayed Z.ÌýSoliman,ÌýMD, MS; Lawton S.ÌýCooper,ÌýMD, MPH; Sana M.ÌýAl-Khatib,ÌýMD, MHS
is active quiz
JAMA Cardiol. 2022; 8(2):182-191. 10.1001/jamacardio.2022.4091
This study summarizes discussions from a National Heart, Lung, and Blood Institute workshop about knowledge gaps and research opportunities in social determinants of health research that address the distinctive aspects of atrial fibrillation.
-
JAMA Cardiology
Special Communication
March 23, 2022
Ersilia M.ÌýDeFilippis,ÌýMD; MelvinÌýEchols,ÌýMD; Philip B.ÌýAdamson,ÌýMD, MSc; Wayne B.ÌýBatchelor,ÌýMD, MHS; Lauren B.ÌýCooper,ÌýMD, MHS; Lawton S.ÌýCooper,ÌýMD, MPH; PatriceÌýDesvigne-Nickens,ÌýMD; Richard T.ÌýGeorge,ÌýMD; Nasrien E.ÌýIbrahim,ÌýMD; MariellÌýJessup,ÌýMD; Dalane W.ÌýKitzman,ÌýMD; Eric S.ÌýLeifer,ÌýPhD; MartinÌýMendoza,ÌýPhD; Ileana L.ÌýPiña,ÌýMD, MPH; MitchellÌýPsotka,ÌýMD, PhD; Fortunato FredÌýSenatore,ÌýMD, PhD; Kenneth M.ÌýStein,ÌýMD; John R.ÌýTeerlink,ÌýMD; Clyde W.ÌýYancy,ÌýMD, MSc; JoAnnÌýLindenfeld,ÌýMD; MonaÌýFiuzat,ÌýPharmD; Christopher M.ÌýO’Connor,ÌýMD; OrlyÌýVardeny,ÌýPharmD, MS; MuthiahÌýVaduganathan,ÌýMD, MPH
is active quiz
JAMA Cardiol. 2022; 7(5):540-548. 10.1001/jamacardio.2022.0161
This Special Communication outlines strategies for heart failure clinical trials to promote enrollment of participants from underrepresented racial and ethnic minority groups.
-
JAMA Cardiology
Original Investigation
November 3, 2021
Douglas L.ÌýMann,ÌýMD; Michael M.ÌýGivertz,ÌýMD; Justin M.ÌýVader,ÌýMD; Randall C.ÌýStarling,ÌýMD, MPH; PalakÌýShah,ÌýMD, MS; Steven E.ÌýMcNulty,ÌýMS; Kevin J.ÌýAnstrom,ÌýPhD; Kenneth B.ÌýMargulies,ÌýMD; Michael S.ÌýKiernan,ÌýMD, MS; ClaudiusÌýMahr,ÌýDO; DivyaÌýGupta,ÌýMD; Margaret M.ÌýRedfield,ÌýMD; AnuradhaÌýLala,ÌýMD; Gregory D.ÌýLewis,ÌýMD; Adam D.ÌýDeVore,ÌýMD, MHS; PatriceÌýDesvigne-Nickens,ÌýMD; Adrian F.ÌýHernandez,ÌýMD, MHS; EugeneÌýBraunwald,ÌýMD; LIFE Investigators
free access
has multimedia
JAMA Cardiol. 2021; 7(1):17-25. 10.1001/jamacardio.2021.4567
This randomized clinical trial evaluates the use of sacubitril/valsartan therapy compared with valsartan alone in US patients with advanced chronic heart failure.
-
JAMA
Original Investigation
November 6, 2018
Barry A.ÌýBorlaug,ÌýMD; Kevin J.ÌýAnstrom,ÌýPhD; Gregory D.ÌýLewis,ÌýMD; Sanjiv J.ÌýShah,ÌýMD; James A.ÌýLevine,ÌýMD, PhD; Gabe A.ÌýKoepp,ÌýMHA; Michael M.ÌýGivertz,ÌýMD; G. MichaelÌýFelker,ÌýMD; Martin M.ÌýLeWinter,ÌýMD; Douglas L.ÌýMann,ÌýMD; Kenneth B.ÌýMargulies,ÌýMD; Andrew L.ÌýSmith,ÌýMD; W. H. WilsonÌýTang,ÌýMD; David J.ÌýWhellan,ÌýMD; Horng H.ÌýChen,ÌýMB, BCh; Victor G.ÌýDavila-Roman,ÌýMD; StevenÌýMcNulty,ÌýMS; PatriceÌýDesvigne-Nickens,ÌýMD; Adrian F.ÌýHernandez,ÌýMD; EugeneÌýBraunwald,ÌýMD; Margaret M.ÌýRedfield,ÌýMD; for the National Heart, Lung, and Blood Institute Heart Failure Clinical Research Network
free access
has multimedia
JAMA. 2018; 320(17):1764-1773. 10.1001/jama.2018.14852
This randomized clinical trial compares the effect of 4 weeks’ administration of inhaled, nebulized inorganic nitrite vs placebo on exercise capacity in patients with heart failure with preserved ejection fraction (HFpEF).
-
ÁñÁ«ÊÓƵ Network Open
Original Investigation
Cardiology
August 31, 2018
Patricia A.ÌýPellikka,ÌýMD; LilinÌýShe,ÌýPhD; Thomas A.ÌýHolly,ÌýMD; GraceÌýLin,ÌýMD; PadminiÌýVaradarajan,ÌýMD; Ramdas G.ÌýPai,ÌýMD; Robert O.ÌýBonow,ÌýMD, MS; Gerald M.ÌýPohost,ÌýMD; Julio A.ÌýPanza,ÌýMD; Daniel S.ÌýBerman,ÌýMD; David L.ÌýPrior,ÌýMBBS, PhD; Federico M.ÌýAsch,ÌýMD; SalvadorÌýBorges-Neto,ÌýMD; PaulÌýGrayburn,ÌýMD; Hussein R.ÌýAl-Khalidi,ÌýPhD; KarolÌýMiszalski-Jamka,ÌýMD, PhD; PatriceÌýDesvigne-Nickens,ÌýMD; Kerry L.ÌýLee,ÌýPhD; Eric J.ÌýVelazquez,ÌýMD; Jae K.ÌýOh,ÌýMD
open access
online only
ÁñÁ«ÊÓƵ Netw Open. 2018; 1(4):e181456. 10.1001/jamanetworkopen.2018.1456
This multicenter diagnostic study determines the intermodality variability of left ventricular ejection fraction (LVEF) measured by echocardiography, gated single-photon emission computed tomography (SPECT), and cardiovascular magnetic resonance (CMR) in patients with coronary artery disease and left ventricular dysfunction.
-
JAMA Cardiology
Original Investigation
September 1, 2017
JavedÌýButler,ÌýMD, MPH; Kevin J.ÌýAnstrom,ÌýPhD; G. MichaelÌýFelker,ÌýMD, MHS; Michael M.ÌýGivertz,ÌýMD; Andreas P.ÌýKalogeropoulos,ÌýMD, MPH, PhD; Marvin A.ÌýKonstam,ÌýMD; Douglas L.ÌýMann,ÌýMD; Kenneth B.ÌýMargulies,ÌýMD; Steven E.ÌýMcNulty,ÌýMS; Robert J.ÌýMentz,ÌýMD; Margaret M.ÌýRedfield,ÌýMD; W. H. WilsonÌýTang,ÌýMD; David J.ÌýWhellan,ÌýMD, MHS; MonicaÌýShah,ÌýMD, MHS; PatriceÌýDesvigne-Nickens,ÌýMD; Adrian F.ÌýHernandez,ÌýMD, MHS; EugeneÌýBraunwald,ÌýMD; for the National Heart Lung and Blood Institute Heart Failure Clinical Research Network
free access
has multimedia
JAMA Cardiol. 2017; 2(9):950-958. 10.1001/jamacardio.2017.2198
This randomized clinical trial analyzes the effects of high-dose spironolactone vs usual care on N-terminal pro-B-type natriuretic peptide levels.
-
JAMA
Original Investigation
August 22, 2017
G. MichaelÌýFelker,ÌýMD, MHS; Kevin J.ÌýAnstrom,ÌýPhD; Kirkwood F.ÌýAdams,ÌýMD; Justin A.ÌýEzekowitz,ÌýMBBCh, MSc; MonaÌýFiuzat,ÌýPhD; NancyÌýHouston-Miller,ÌýRN, BSN; James L.ÌýJanuzziÌýJr,ÌýMD; Daniel B.ÌýMark,ÌýMD, MPH; Ileana L.ÌýPiña,ÌýMD, MPH; GayleÌýPassmore,ÌýPMP; David J.ÌýWhellan,ÌýMD, MHS; HongqiuÌýYang,ÌýPhD; Lawton S.ÌýCooper,ÌýMD, MPH; Eric S.ÌýLeifer,ÌýPhD; PatriceÌýDesvigne-Nickens,ÌýMD; Christopher M.ÌýO’Connor,ÌýMD
free access
JAMA. 2017; 318(8):713-720. 10.1001/jama.2017.10565
This randomized clinical trial investigates whether reducing natriuretic peptide levels by titrating medication to reach the target of less than 1000 pg/mL in patients with heart failure and reduced ejection fraction improves clinical outcomes.
-
JAMA
Original Investigation
May 16, 2017
Gregory D.ÌýLewis,ÌýMD; RajeevÌýMalhotra,ÌýMD; Adrian F.ÌýHernandez,ÌýMD, MHS; Steven E.ÌýMcNulty,ÌýMS; AndrewÌýSmith,ÌýMD; G. MichaelÌýFelker,ÌýMD, MHS; W. H. WilsonÌýTang,ÌýMD; Shane J.ÌýLaRue,ÌýMD; Margaret M.ÌýRedfield,ÌýMD; Marc J.ÌýSemigran,ÌýMD; Michael M.ÌýGivertz,ÌýMD; PeterÌýVan Buren,ÌýMD; DavidÌýWhellan,ÌýMD; Kevin J.ÌýAnstrom,ÌýPhD; Monica R.ÌýShah,ÌýMD, MHS; PatriceÌýDesvigne-Nickens,ÌýMD; JavedÌýButler,ÌýMD; EugeneÌýBraunwald,ÌýMD; for the NHLBI Heart Failure Clinical Research Network
free access
JAMA. 2017; 317(19):1958-1966. 10.1001/jama.2017.5427
This randomized clinical trial investigates the efficacy of oral iron supplementation for improvement of exercise capacity in adult patients with heart failure with reduced left ventricular ejection fraction.
-
JAMA
Brief Report
January 10, 2001
Judith S. Hochman, MD; Lynn A. Sleeper, ScD; Harvey D. White, DSc; Vladimir Dzavik, MD; S. Chiu Wong, MD; Venu Menon, MD; John G. Webb, MD; Richard Steingart, MD; Michael H. Picard, MD; Mark A. Menegus, MD; Jean Boland, MD; Timothy Sanborn, MD; Christopher E. Buller, MD; Sharada Modur, MS; Robert Forman, MD; Patrice Desvigne-Nickens, MD; Alice K. Jacobs, MD; James N. Slater, MD; Thierry H. LeJemtel, MD; for the SHOCK Investigators
free access
JAMA. 2001; 285(2):190-192. 10.1001/jama.285.2.190